http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 02 Jun 2026 19:28:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Denoyer+Bernard/26593874.html si-local-file:///var/storage/secattach/20260602/26593874.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Denoyer+Bernard/26593874.html Tue, 02 Jun 2026 19:28:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Denoyer+Bernard/26593874.html si-local-file:///var/storage/secattach/20260602/26593874.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Denoyer+Bernard/26593874.html Tue, 02 Jun 2026 19:28:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Denoyer+Bernard/26593874.html si-local-file:///var/storage/secattach/20260602/26593874.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Denoyer+Bernard/26593874.html Tue, 02 Jun 2026 19:28:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Simon+Willy+Jules/26585504.html si-local-file:///var/storage/secattach/20260601/26585504.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Simon+Willy+Jules/26585504.html Mon, 01 Jun 2026 18:49:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Simon+Willy+Jules/26585504.html si-local-file:///var/storage/secattach/20260601/26585504.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Simon+Willy+Jules/26585504.html Mon, 01 Jun 2026 18:49:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Simon+Willy+Jules/26585504.html si-local-file:///var/storage/secattach/20260601/26585504.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Simon+Willy+Jules/26585504.html Mon, 01 Jun 2026 18:49:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+BRANCACCIO+JOHN+P/26585501.html si-local-file:///var/storage/secattach/20260601/26585501.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+BRANCACCIO+JOHN+P/26585501.html Mon, 01 Jun 2026 18:45:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+BRANCACCIO+JOHN+P/26585501.html si-local-file:///var/storage/secattach/20260601/26585501.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+BRANCACCIO+JOHN+P/26585501.html Mon, 01 Jun 2026 18:45:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+BRANCACCIO+JOHN+P/26585501.html si-local-file:///var/storage/secattach/20260601/26585501.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+BRANCACCIO+JOHN+P/26585501.html Mon, 01 Jun 2026 18:45:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Dempsey+Robert+John/26541879.html si-local-file:///var/storage/secattach/20260522/26541879.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Dempsey+Robert+John/26541879.html Fri, 22 May 2026 16:16:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Dempsey+Robert+John/26541879.html si-local-file:///var/storage/secattach/20260522/26541879.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Dempsey+Robert+John/26541879.html Fri, 22 May 2026 16:16:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Dempsey+Robert+John/26541879.html si-local-file:///var/storage/secattach/20260522/26541879.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Dempsey+Robert+John/26541879.html Fri, 22 May 2026 16:16:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Shah+Keeren+Rameshchandra/26541888.html si-local-file:///var/storage/secattach/20260522/26541888.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Shah+Keeren+Rameshchandra/26541888.html Fri, 22 May 2026 16:16:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Shah+Keeren+Rameshchandra/26541888.html si-local-file:///var/storage/secattach/20260522/26541888.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Shah+Keeren+Rameshchandra/26541888.html Fri, 22 May 2026 16:16:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Shah+Keeren+Rameshchandra/26541888.html si-local-file:///var/storage/secattach/20260522/26541888.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+18++Filed+by%3A+Shah+Keeren+Rameshchandra/26541888.html Fri, 22 May 2026 16:16:00 -0400 O.38528770 OKYO OKYO http://www.streetinsider.com/Board+Changes/OKYO+Pharma+appoints+Marta+Sacchetti+to+scientific+advisory+board/26517057.html <p>OKYO Pharma Limited (NASDAQ: OKYO) announced the appointment of Marta Sacchetti, MD, PhD, to its Scientific Advisory Board. The clinical-stage biopharmaceutical company develops therapies for neuropathic corneal pain and inflammatory eye diseases.</p> <p>Sacchetti serves as Associate Professor of Ophthalmology at Link University in Rome, Italy. She previously worked as Global Head of Clinical Development, Ophthalmology & Neurotrophins at Dompé Farmaceutici. Her research focuses on degenerative, allergic, and neuroimmune diseases of the cornea and ocular surface.</p> <p>"Her expertise in neuro-inflammatory corneal diseases brings critical insight into addressing the underlying nerve dysfunction driving neuropathic corneal pain and will help shape our global clinical development http://www.streetinsider.com/Board+Changes/OKYO+Pharma+appoints+Marta+Sacchetti+to+scientific+advisory+board/26517057.html Tue, 19 May 2026 07:00:21 -0400 OKYO http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++OKYO+Pharma+Ltd+++++++++++For%3A+May+19/26517093.html si-local-file:///var/storage/secattach/20260519/26517093.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++OKYO+Pharma+Ltd+++++++++++For%3A+May+19/26517093.html Tue, 19 May 2026 07:00:00 -0400 O.38528770 OKYO http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++OKYO+Pharma+Ltd+++++++++++For%3A+May+19/26517093.html si-local-file:///var/storage/secattach/20260519/26517093.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++OKYO+Pharma+Ltd+++++++++++For%3A+May+19/26517093.html Tue, 19 May 2026 07:00:00 -0400 O.38528770 OKYO http://www.streetinsider.com/Press+Releases/OKYO+Expands+Scientific+Advisory+Board+with+the+Appointment+of+International+Expert+Marta+Sacchetti%2C+MD%2C+PhD/26517018.html <ul type="disc"><li>Dr. Sacchetti brings international expertise in clinical and translational research on ocular inflammatory and degenerative disease</li><li>OKYO’s introduction to the broader ophthalmology community at ASCRS drove strong engagement at Eyecelerator and ARVO</li></ul> <p>LONDON and NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: <a href="https://www.globenewswire.com/Tracker?data=neTAcXPY-2rcanBq1hEImXc5FzAC-0oco9fD8twGCNWnhhhy7yLkRzrbNIxY7cosIUthrzaSPOJuv5YxVbtVPVJA5MyLkJ6AeMh_lZtxE7ZBKLcjI7y1OeEcOnv965uC" rel="nofollow" target="_blank">OKYO</a>), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced the expansion of their Scientific Advisory Board (SAB) with the appointment of Marta Sacchetti, MD, PhD. This appointment further enhances the Company’s global scientific network with http://www.streetinsider.com/Press+Releases/OKYO+Expands+Scientific+Advisory+Board+with+the+Appointment+of+International+Expert+Marta+Sacchetti%2C+MD%2C+PhD/26517018.html Tue, 19 May 2026 07:00:00 -0400 OKYO http://www.streetinsider.com/Globe+Newswire/OKYO+Expands+Scientific+Advisory+Board+with+the+Appointment+of+International+Expert+Marta+Sacchetti%2C+MD%2C+PhD/26517018.html <ul type="disc"><li>Dr. Sacchetti brings international expertise in clinical and translational research on ocular inflammatory and degenerative disease</li><li>OKYO’s introduction to the broader ophthalmology community at ASCRS drove strong engagement at Eyecelerator and ARVO</li></ul> <p>LONDON and NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: <a href="https://www.globenewswire.com/Tracker?data=neTAcXPY-2rcanBq1hEImXc5FzAC-0oco9fD8twGCNWnhhhy7yLkRzrbNIxY7cosIUthrzaSPOJuv5YxVbtVPVJA5MyLkJ6AeMh_lZtxE7ZBKLcjI7y1OeEcOnv965uC" rel="nofollow" target="_blank">OKYO</a>), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced the expansion of their Scientific Advisory Board (SAB) with the appointment of Marta Sacchetti, MD, PhD. This appointment further enhances the Company’s global scientific network with http://www.streetinsider.com/Globe+Newswire/OKYO+Expands+Scientific+Advisory+Board+with+the+Appointment+of+International+Expert+Marta+Sacchetti%2C+MD%2C+PhD/26517018.html Tue, 19 May 2026 07:00:00 -0400 OKYO http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506900.html si-local-file:///var/storage/secattach/20260515/26506900.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506900.html Fri, 15 May 2026 16:41:00 -0400 O.38528770 OKYO http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506900.html si-local-file:///var/storage/secattach/20260515/26506900.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506900.html Fri, 15 May 2026 16:41:00 -0400 O.38528770 OKYO http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26500491.html si-local-file:///var/storage/secattach/20260515/26500491.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26500491.html Fri, 15 May 2026 09:01:00 -0400 O.38528770 OKYO http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26500491.html si-local-file:///var/storage/secattach/20260515/26500491.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26500491.html Fri, 15 May 2026 09:01:00 -0400 O.38528770 OKYO http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499821.html si-local-file:///var/storage/secattach/20260515/26499821.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++OKYO+Pharma+Ltd++++++++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499821.html Fri, 15 May 2026 08:03:00 -0400 O.38528770 OKYO